Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,657 | 3,020 | 4,909 | 6,351 | N/A |
| Other current assets | 6,953 | 205 | 205 | 196 | 0 |
| TOTAL | $19,610 | $3,483 | $5,528 | $6,755 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 123 | 657 | 674 | 691 | N/A |
| Other Non-Current Assets | 233 | 0 | 0 | 0 | 0 |
| TOTAL | $356 | $657 | $674 | $691 | $N/A |
| Total Assets | $19,967 | $4,140 | $6,202 | $7,446 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,170 | 2,257 | 2,259 | 1,341 | 0 |
| TOTAL | $5,330 | $2,257 | $2,259 | $1,341 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 43 | 188 | 186 | 183 | 0 |
| TOTAL | $43 | $188 | $186 | $183 | $N/A |
| Total Liabilities | $5,373 | $2,445 | $2,445 | $1,524 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,680 | 42,285 | N/A | 1,582 | 1,116 |
| Common Shares | 42 | 2 | 2 | 55 | N/A |
| Retained earnings | -111,125 | -162,052 | -159,876 | -157,550 | N/A |
| Other shareholders' equity | 0 | 21 | 21 | 21 | 0 |
| TOTAL | $14,594 | $1,695 | $3,757 | $5,922 | $N/A |
| Total Liabilities And Equity | $19,967 | $4,140 | $6,202 | $7,446 | $0 |